There were two studies done to test the effectiveness of Humira on patients with ulcerative colitis. Between 16% and 18% of patients receiving the drug achieved remission. Patients included in these studies had never received any other anti-TNF drug, such as Remicade. It's not known if Humira will be effective in patients with ulcerative colitis who have been treated with another anti-TNF drug.
The side effects in these studies were similar to those seen in other studies of Humira: infections, injection-site reactions, headaches, and rashes.
More about Humira:
- Humira Crosses The Placenta During Pregnancy
- Humira Approved To Treat Ulcerative Colitis In Europe
- Tumor Necrosis Factor-Alpha
US Food And Drug Association. "FDA approves Humira to treat ulcerative colitis." FDA.gov. 28 Sept 2012. 1 Oct 2012.